Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Heron Therapeutics (HRTX) Times Interest Earned: 2012-2016

Historic Times Interest Earned for Heron Therapeutics (HRTX) over the last 1 years, with Dec 2016 value amounting to -$63.56.

  • Heron Therapeutics' Times Interest Earned was N/A to -$63.56 in Q4 2016 from the same period last year, while for Dec 2016 it was -$64.13, marking a year-over-year change of. This contributed to the annual value of -$1.91 for FY2024, which is 93.32% up from last year.
  • According to the latest figures from Q4 2016, Heron Therapeutics' Times Interest Earned is -$63.56, which was down 4.89% from -$60.59 recorded in Q3 2013.
  • In the past 5 years, Heron Therapeutics' Times Interest Earned ranged from a high of -$23.61 in Q1 2012 and a low of -$74.19 during Q2 2013.
  • Moreover, its 1-year median value for Times Interest Earned was -$63.56 (2016), whereas its average is -$63.56.
  • Data for Heron Therapeutics' Times Interest Earned shows a maximum YoY tumbled of 168.72% (in 2013) over the last 5 years.
  • Over the past 3 years, Heron Therapeutics' Times Interest Earned (Quarterly) stood at -$23.61 in 2012, then crashed by 168.72% to -$60.59 in 2013, then reached -$63.56 in 2016.
  • Its Times Interest Earned stands at -$63.56 for Q4 2016, versus -$60.59 for Q3 2013 and -$74.19 for Q2 2013.